Attachment_C_-_Pharmacy_Drug_Plan_Formulary.xlsx

This is a Pharmacy Drug Plan Formulary attachment for Orange County, Florida's Medicare Supplemental Plans and Medicare Part D Employer Group Waiver Plans procurement (Y26-151). The formulary worksheet requires respondents to classify 100 pharmaceutical drugs across two plan tiers—Low Plan and High Plan—using four formulary categories: Generic, Preferred Brand, Non-Preferred Brand, and Specialty. The drugs listed represent a comprehensive range of therapeutic classes including biologics (HUMIRA, ENBREL, STELARA), specialty medications (POMALYST, GILENYA), diabetes treatments (HUMALOG, TRESIBA, OZEMPIC), cardiovascular drugs (ELIQUIS, XARELTO, ENTRESTO), and other chronic condition therapies. Sealed responses for the Medicare Supplemental and Part D plans were due by 4:00 pm EST on Thursday, May 7, 2026, and all submissions were required to be made electronically through the OpenGov e-Procurement Platform, with hand-delivery, mail, telephone, fax, and email submissions being prohibited.

The formulary worksheet does not specify pricing terms, co-payment structures, or out-of-pocket maximums within the attachment itself. The document appears to be a template requiring bidders to populate their specific formulary tier classifications based on their current formulary lists, indicating that pricing and benefit design details would likely be addressed in other sections of the solicitation. No incumbent information, set-asides, or funding amounts are documented in this formulary attachment, as it serves primarily as a technical specification tool for evaluating and comparing how each respondent's drug coverage aligns with the County's requirements for both Low and High plan options.